Abstract
While the major application of gels has historically been as delivery systems for small molecule and protein/peptide drugs, the benefits of gels as delivery vehicles are being increasingly translated to the field of subunit vaccine delivery. This chapter will present a summary of gel systems commonly employed to date in the delivery of subunit antigens, categorised according to mechanism of gelation and principal gelling component. Examples of preclinical and also clinical studies in which gels have been employed as delivery systems for vaccines will be given. Gels as bulk delivery systems will be focused on in this chapter; however, the reader’s attention is also drawn to the increasingly popular application of nanogels (nanosized polymeric gels) as vaccine delivery systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarwal P, Rupenthal ID (2013) Injectable implants for the sustained release of protein and peptide drugs. Drug Discov Today 18(7–8):337–349
Almdal K, Dyre J, Hvidt S, Kramer O (1993) Towards a phenomenological definition of the term ‘gel’. Polym Gels Networks 1(1):5–17
Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, Jiskoot W (2006) Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release 111(1–2):107–116
Berger J, Reist M, Chenite A, Felt-Baeyens O, Mayer JM, Gurny R (2005) Pseudo-thermosetting chitosan hydrogels for biomedical application. Int J Pharm 288(1):17–25
Brown W, Schillen K, Almgren M, Hvidt S, Bahadur P (1991) Micelle and gel formation in a poly(ethylene oxide)/poly(propylene oxide)/poly(ethylene oxide) triblock copolymer in water solution: dynamic and static light scattering and oscillatory shear measurements. J Phys Chem 95(4):1850–1858
Bueter CL, Lee CK, Rathinam VAK, Healy GJ, Taron CH, Specht CA, Levitz SM (2011) Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis. J Biol Chem 286(41):35447–35455
Cabana A, Aı̈t-Kadi A, Juhász J (1997) Study of the gelation process of polyethylene oxidea–polypropylene oxideb–polyethylene oxidea copolymer (Poloxamer 407) aqueous solutions. J Colloid Interface Sci 190(2):307–312
Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, Hoemann CD, Leroux JC, Atkinson BL, Binette F, Selmani A (2000) Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21(21):2155–2161
Chenite A, Buschmann M, Wang D, Chaput C, Kandani N (2001) Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions. Carbohydr Polym 46(1):39–47
Chitkara D, Shikanov A, Kumar N, Domb AJ (2006) Biodegradable injectable in situ depot-forming drug delivery systems. Macromol Biosci 6(12):977–990
Cho J, Heuzey M-C, Bégin A, Carreau PJ (2005) Physical gelation of chitosan in the presence of β-glycerophosphate: the effect of temperature. Biomacromolecules 6(6):3267–3275
Christie RJ, Findley DJ, Dunfee M, Hansen RD, Olsen SC, Grainger DW (2006) Photopolymerized hydrogel carriers for live vaccine ballistic delivery. Vaccine 24(9):1462–1469
Chung HJ, Lee Y, Park TG (2008) Thermo-sensitive and biodegradable hydrogels based on stereocomplexed Pluronic multi-block copolymers for controlled protein delivery. J Control Release 127(1):22–30
Coeshott CM, Smithson SL, Verderber E, Samaniego A, Blonder JM, Rosenthal GJ, Westerink MAJ (2004) Pluronic® F127-based systemic vaccine delivery systems. Vaccine 22(19):2396–2405
Çokçalışkan C, Özyörük F, Gürsoy RN, Alkan M, Günbeyaz M, Arca HÇ, Uzunlu E, Şenel S (2013) Chitosan-based systems for intranasal immunization against foot-and-mouth disease. Pharm Dev Technol. doi:10.3109/10837450.2013.763263:1-8
Cole DJ, Gattoni-Celli S, McClay EF, Metcalf JS, Brown JM, Nabavi N, Newton DA, Woolhiser CB, Wilson MC, Vournakis JN (1997) Characterization of a sustained-release delivery system for combined cytokine/peptide vaccination using a poly-N-acetyl glucosamine-based polymer matrix. Clin Cancer Res 3(6):867–873
Cranage MP, Fraser CA, Stevens Z, Huting J, Chang M, Jeffs SA, Seaman MS, Cope A, Cole T, Shattock RJ (2009) Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses. Mucosal Immunol 3(1):57–68
Cranage MP, Fraser CA, Cope A, McKay PF, Seaman MS, Cole T, Mahmoud AN, Hall J, Giles E, Voss G, Page M, Almond N, Shattock RJ (2011) Antibody responses after intravaginal immunisation with trimeric HIV-1CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation. Vaccine 29(7):1421–1430
Danforth HD, Lee EH, Martin A, Dekich M (1997) Evaluation of a gel-immunization technique used with two different Immucox vaccine formulations in battery and floor-pen trials with broiler chickens. Parasitol Res 83(5):445–451
Dasgupta T, Lee EH (2000) A gel delivery system for coccidiosis vaccine: uniformity of distribution of oocysts. Can Vet J 41(8):613–616
Dey AK, Burke B, Sun Y, Hartog K, Heeney JL, Montefiori D, Srivastava IK, Barnett SW (2012) Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein. Vaccine 30(17):2749–2759
Dumortier G, Grossiord JL, Agnely F, Chaumeil JC (2006) A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 23(12):2709–2728
Ellis RW (2001) Technologies for the design, discovery, formulation and administration of vaccines. Vaccine 19(17–19):2681–2687
Felt O, Einmahl S, Gurny R, Furrer P, Baeyens V (2002) Polymeric systems for ophthalmic drug delivery. In: Dumitriu S (ed) Polymeric biomaterials, revised and expanded, 2nd edn. Marcel Dekker, New York
Ganguly S, Dash AK (2004) A novel in situ gel for sustained drug delivery and targeting. Int J Pharm 276(1–2):83–92
Gombotz WR, Wee SF (1998) Protein release from alginate matrices. Adv Drug Deliv Rev 31(3):267–285
Gong C-Y, Shi S, Peng X-Y, Kan B, Yang L, Huang M-J, Luo F, Zhao X, Wei Y-Q, Qian Z-Y (2009) Biodegradable thermosensitive injectable PEG-PCL-PEG hydrogel for bFGF antigen delivery to improve humoral immunity. Growth Factors 27(6):377–383
Gordon S, Saupe A, McBurney W, Rades T, Hook S (2008) Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery. J Pharm Pharmacol 60(12):1591–1600
Gordon S, Teichmann E, Young K, Finnie K, Rades T, Hook S (2010) In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery. Eur J Pharm Sci 41(2):360–368
Gordon S, Young K, Wilson R, Rizwan S, Kemp R, Rades T, Hook S (2012) Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems. J Liposome Res 22(3):193–204
Günbeyaz M, Faraji A, Özkul A, Puralı N, Şenel S (2010) Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1). Eur J Pharm Sci 41(3–4):531–545
Gupta P, Vermani K, Garg S (2002) Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov Today 7(10):569–579
Han I-K, Kim YB, Kang H-S, Sul D, Jung W-W, Cho HJ, Oh Y-K (2006) Thermosensitive and mucoadhesive delivery systems of mucosal vaccines. Methods 38(2):106–111
He C, Kim SW, Lee DS (2008) In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release 127(3):189–207
Hori Y, Winans AM, Huang CC, Horrigan EM, Irvine DJ (2008) Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy. Biomaterials 29(27):3671–3682
Hvidt S, Joergensen EB, Brown W, Schillen K (1994) Micellization and gelation of aqueous solutions of a triblock copolymer studied by rheological techniques and scanning calorimetry. J Phys Chem 98(47):12320–12328
Ishihara M, Obara K, Nakamura S, Fujita M, Masuoka K, Kanatani Y, Takase B, Hattori H, Morimoto Y, Ishihara M, Maehara T, Kikuchi M (2006) Chitosan hydrogel as a drug delivery carrier to control angiogenesis. J Artif Organs 9(1):8–16
Jeong B, Kim SW, Bae YH (2002) Thermosensitive sol–gel reversible hydrogels. Adv Drug Deliv Rev 54(1):37–51
Kabanov AV, Batrakova EV, Alakhov VY (2002) Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 82(2–3):189–212
Kashyap N, Kumar N, Kumar MNVR (2005) Hydrogels for pharmaceutical and biomedical applications. Crit Rev Ther Drug Carrier Syst 22(2):107–150
Klouda L, Mikos AG (2008) Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 68(1):34–45
Kojarunchitt T, Hook S (2012) Thermoresponsive chitosan and poloxamer 407 hydrogels for drug and vaccine delivery. In: Câmara FV, Ferreira LJ (eds) Hydrogels: synthesis, characterization and applications. Biochemistry research trends. Nova Biomedical, Waltham
Kojarunchitt T, Hook S, Rizwan S, Rades T, Baldursdottir S (2011) Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes. Int J Pharm 408(1–2):20–26
Krashias G, Simon A-K, Wegmann F, Kok W-L, Ho L-P, Stevens D, Skehel J, Heeney JL, Moghaddam AE, Sattentau QJ (2010) Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer. Vaccine 28(13):2482–2489
Kumar S, Himmelstein KJ (1995) Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose. J Pharm Sci 84(3):344–348
Lewis DJ, Fraser CA, Mahmoud AN, Wiggins RC, Woodrow M, Cope A, Cai C, Giemza R, Jeffs SA, Manoussaka M, Cole T, Cranage MP, Shattock RJ, Lacey CJ (2011) Phase I randomised clinical trial of an HIV-1CN54, Clade C, trimeric envelope vaccine candidate delivered vaginally. PLoS One 6(9):e25165
Li H, Willingham SB, Ting JP-Y, Re F (2008) Cutting edge: inflammasome activation by alum and alum’s adjuvant effect are mediated by NLRP3. J Immunol 181(1):17–21
Lofthouse S (2002) Immunological aspects of controlled antigen delivery. Adv Drug Deliv Rev 54(6):863–870
Maitre N, Brown JM, Demcheva M, Kelley JR, Lockett MA, Vournakis J, Cole DJ (1999) Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination. Clin Cancer Res 5(5):1173–1182
Mao J, Kondu S, Ji H-F, McShane MJ (2006) Study of the near-neutral pH-sensitivity of chitosan/gelatin hydrogels by turbidimetry and microcantilever deflection. Biotechnol Bioeng 95(3):333–341
Murdan S (2005) Organogels in drug delivery. Expert Opin Drug Deliv 2(3):489–505
Murdan S, Bvd B, Gregoriadis G, Florence AT (1999a) Water-in-sorbitan monostearate organogels (water-in-oil gels). J Pharm Sci 88(6):615–619
Murdan S, Gregoriadis G, Florence AT (1999b) Sorbitan monostearate/polysorbate 20 organogels containing niosomes: a delivery vehicle for antigens? Eur J Pharm Sci 8(3):177–185
Nguyen CL, Bui JT, Demcheva M, Vournakis JN, Cole DJ, Gillanders WE (2001) Sustained release of granulocyte-macrophage colony-stimulating factor from a modular peptide-based cancer vaccine alters vaccine microenvironment and enhances the antigen-specific T-cell response. J Immunother 24(5):420–429
Oh Y-K, Park J-S, Yoon H, Kim C-K (2003) Enhanced mucosal and systemic immune responses to a vaginal vaccine coadministered with RANTES-expressing plasmid DNA using in situ-gelling mucoadhesive delivery system. Vaccine 21(17–18):1980–1988
Park J-S, Oh Y-K, Yoon H, Kim JM, Kim C-K (2002) In situ gelling and mucoadhesive polymer vehicles for controlled intranasal delivery of plasmid DNA. J Biomed Mater Res 59(1):144–151
Park J-S, Oh Y-K, Kang M-J, Kim C-K (2003) Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems. J Med Virol 70(4):633–641
Peluso G, Petillo O, Ranieri M, Santin M, Ambrosic L, Calabró D, Avallone B, Balsamo G (1994) Chitosan-mediated stimulation of macrophage function. Biomaterials 15(15):1215–1220
Porporatto C, Bianco ID, Riera CM, Correa SG (2003) Chitosan induces different l-arginine metabolic pathways in resting and inflammatory macrophages. Biochem Biophys Res Commun 304(2):266–272
Porporatto C, Bianco ID, Correa SG (2005) Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration. J Leukoc Biol 78(1):62–69
Prego C, García M, Torres D, Alonso MJ (2005) Transmucosal macromolecular drug delivery. J Control Release 101(1–3):151–162
Qin C, Gao J, Wang L, Zeng L, Liu Y (2006) Safety evaluation of short-term exposure to chitooligomers from enzymic preparation. Food Chem Toxicol 44(6):855–861
Ruel-Gariépy E, Leroux J-C (2004) In situ-forming hydrogels—review of temperature-sensitive systems. Eur J Pharm Biopharm 58(2):409–426
Ruel-Gariépy E, Leclair G, Hildgen P, Gupta A, Leroux JC (2002) Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. J Control Release 82(2–3):373–383
Salem ML, Demcheva M, Gillanders WE, Cole DJ, Vournakis JN (2010) Poly-N-acetyl glucosamine gel matrix as a non-viral delivery vector for DNA-based vaccination. Anticancer Res 30(10):3889–3894
Sood N, Nagpal S, Nanda S, Bhardwaj A, Mehta A (2013) An overview on stimuli responsive hydrogels as drug delivery system. J Control Release. doi:10.1016/j.jconrel.2013.02.023
Tecante A, del Carmen Núñez Santiago M (2012) Solution properties of κ-carrageenan and its interaction with other polysaccharides in aqueous media. In: De Vicente J (ed) Rheology. InTech, Croatias
Tomihata K, Ikada Y (1997) In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials 18(7):567–575
VandeVord PJ, Matthew HWT, DeSilva SP, Mayton L, Wu B, Wooley PH (2002) Evaluation of the biocompatibility of a chitosan scaffold in mice. J Biomed Mater Res 59(3):585–590
Velasquez LS, Shira S, Berta AN, Kilbourne J, Medi BM, Tizard I, Ni Y, Arntzen CJ, Herbst-Kralovetz MM (2011) Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine. Vaccine 29(32):5221–5231
Westerink MAJ, Smithson SL, Srivastava N, Blonder J, Coeshott C, Rosenthal GJ (2001) ProJuvant™ (Pluronic F127®/chitosan) enhances the immune response to intranasally administered tetanus toxoid. Vaccine 20(5–6):711–723
Winter HH, Chambon F (1986) Analysis of linear viscoelasticity of a crosslinking polymer at the gel point. J Rheol 30(2):367–382
Wu QJ, Zhu XC, Xiao X, Wang P, Dk X, Gong CY, Wang YS, Yang L, Wei YQ (2011) A novel vaccine delivery system: Biodegradable nanoparticles in thermosensitive hydrogel. Growth Factors 29(6):290–297
Wu Q, Gong C, Shi S, Wang Y, Huang M, Yang L, Zhao X, Wei Y, Qian Z (2012a) Mannan loaded biodegradable and injectable thermosensitive PCL-PEG-PCL hydrogel for vaccine delivery. Soft Mater 10(4):472–486
Wu Y, Wei W, Zhou M, Wang Y, Wu J, Ma G, Su Z (2012b) Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization. Biomaterials 33(7):2351–2360
Wu Y, Wu S, Hou L, Wei W, Zhou M, Su Z, Wu J, Chen W, Ma G (2012c) Novel thermal-sensitive hydrogel enhances both humoral and cell-mediated immune responses by intranasal vaccine delivery. Eur J Pharm Biopharm 81(3):486–497
Zhao Z, Leong KW (1996) Controlled delivery of antigens and adjuvants in vaccine development. J Pharm Sci 85(12):1261–1270
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gordon, S. (2015). Gels as Vaccine Delivery Systems. In: Foged, C., Rades, T., Perrie, Y., Hook, S. (eds) Subunit Vaccine Delivery. Advances in Delivery Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1417-3_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1417-3_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1416-6
Online ISBN: 978-1-4939-1417-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)